|Articles|February 1, 2013
- BioPharm International-02-01-2013
- Volume 26
- Issue 2
BioPharm International, February 2013 Issue (PDF)
Viral Vaccines
Advertisement
Articles in this issue
over 12 years ago
Assessing Development Needs for Biobetters and Biosimilarsover 12 years ago
Facility Design and Operation: A Primerover 12 years ago
Offering a Biopharma View of Social Mediaover 12 years ago
GMP Compliance Becomes Prominent Enforcement Issueover 12 years ago
Therapeutic Antibodies in Reviewover 12 years ago
The Vaccine Sceneover 12 years ago
Automated Concentration and Diafiltration of Multiple siRNA Samplesover 12 years ago
End of the Dedicated CMO?over 12 years ago
Viral Vaccine Manufacturingover 12 years ago
Navigating Emerging Markets: Eastern EuropeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
5
